Sort
82,697 grants matching “vaccine development”
Development of Technologies to Facilitate the Use of and Response to Vaccines
$2,045,144Laurence Lemiale · Emergent Product Development Gaithersbur · N01 · FY2013 · AI
SPORE for Translational Approaches to Brain Cancer
$2,044,971Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2023 · CA
NIAID Preclinical Development Support
$2,044,894Advanced Bioscience Laboratories, Inc. · N01 · FY2012 · AI
Vaccine and Treatment Evaluation Units
$2,044,564Nadine Georges Rouphael · Emory University · UM1 · FY2021 · AI
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
$2,044,217Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2023 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2019 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2021 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2022 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2020 · AI
Enhancing racial and ethnic diversity inCOVID-19 research participation through storytelling (COVIDstory)
$2,043,738Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · U01 · FY2020 · CA
Papillomavirus Virion Proteins and Vaccines
$2,043,490John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Influenza Vaccine Development
$2,042,985Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Emerging respiratory viruses - pathogenesis and countermeasures
$2,042,870Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CORE C: Structure & Protein Engineering Core
$2,042,293Jason Scott McLellan · Albert Einstein College Of Medicine · U19 · FY2025 · AI
Improving the safety profile of DNA prime - protein boost HIV vaccinations
$2,042,130Egil Lien · Univ Of Massachusetts Med Sch Worcester · U19 · FY2011 · AI
EVALUATION OF THE IMMUNOGENICITY AND EFFICACY OF HIV-1 CLADE C OLIGOMERIC ENVELOPE PROTEIN DELIVERED WITH ADVAX DELTA INULIN ADJUVANT BY INTRAMUSCULAR AND INTRAPULMONARY ROUTES
$2,041,729Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS
$2,041,686University Of Virginia Charlottesville · U54 · FY2000 · HD
Thymic vaccination: Manipulating the T cell repertoire
$2,041,678Dana-Farber Cancer Institute · R01 · FY2001 · AI
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$2,041,466Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
CHARACTERIZING AND IMPROVING HUMANIZED IMMUNE SYSTEM MOUSE MODELS (IMM-HIS)
$2,041,443Julie Lang · University Of Colorado Denver · N01 · FY2020 · AI
Correlates of protective immunity to HCV and rational vaccine design
$2,040,307Arash Grakoui · Emory University · U19 · FY2022 · AI
HIV LCMV vaccines
$2,040,198Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2010 · AI
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$2,039,904Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Recombinant Subunit Vaccine/Prevention of West Nile Vir*
$2,039,391Hawaii Biotech, Inc. · R44 · FY2005 · NS